BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kirwin T, Gomes A, Amin R, Sufi A, Goswami S, Wang B. Mechanisms underlying the therapeutic potential of mesenchymal stem cells in atherosclerosis. Regen Med 2021;16:669-82. [PMID: 34189963 DOI: 10.2217/rme-2021-0024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang S, Xiao X, Huang Z, Chen Q, Li C, Niu C, Yang Y, Yang L, Feng L. Human adipose-derived mesenchymal stem cells-based microspheres ameliorate atherosclerosis progression in vitro. Stem Cells Dev 2023. [PMID: 36762935 DOI: 10.1089/scd.2022.0287] [Reference Citation Analysis]
2 Jung YH, Chae CW, Chang HS, Choi GE, Lee HJ, Han HJ. Silencing SIRT5 induces the senescence of UCB-MSCs exposed to TNF-α by reduction of fatty acid β-oxidation and anti-oxidation. Free Radic Biol Med 2022;192:1-12. [PMID: 36096355 DOI: 10.1016/j.freeradbiomed.2022.09.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li Q, Huang Z, Pang Z, Wang Q, Gao J, Chen J, Wang Z, Tan H, Li S, Xu F, Chen J, Liu M, Weng X, Yang H, Song Y, Qian J, Ge J. Targeted delivery of platelet membrane modified extracellular vesicles into atherosclerotic plaque to regress atherosclerosis. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.138992] [Reference Citation Analysis]
4 Yao G, Qi J, Li X, Tang X, Li W, Chen W, Xia N, Wang S, Sun L. Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs. Stem Cell Res Ther 2022;13:328. [PMID: 35850768 DOI: 10.1186/s13287-022-03002-y] [Reference Citation Analysis]
5 S S, Dahal S, Bastola S, Dayal S, Yau J, Ramamurthi A. Stem Cell Based Approaches to Modulate the Matrix Milieu in Vascular Disorders. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.879977] [Reference Citation Analysis]
6 Zhang N, Luo Y, Zhang H, Zhang F, Gao X, Shao J. Exosomes Derived from Mesenchymal Stem Cells Ameliorate the Progression of Atherosclerosis in ApoE-/- Mice via FENDRR. Cardiovasc Toxicol 2022. [PMID: 35344140 DOI: 10.1007/s12012-022-09736-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Suh MR, Lim I, Kim J, Yang PS, Choung JS, Sim HR, Ha SC, Kim M. Efficacy of Cord Blood Cell Therapy for Hutchinson-Gilford Progeria Syndrome-A Case Report. Int J Mol Sci 2021;22:12316. [PMID: 34830197 DOI: 10.3390/ijms222212316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ma T, Zhang Z, Chen Y, Su H, Deng X, Liu X, Fan Y. Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy. Int J Mol Sci 2021;22:12166. [PMID: 34830052 DOI: 10.3390/ijms222212166] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
9 Sun L, He X, Zhang T, Han Y, Tao G. Knockdown of mesenchymal stem cell‑derived exosomal LOC100129516 suppresses the symptoms of atherosclerosis via upregulation of the PPARγ/LXRα/ABCA1 signaling pathway. Int J Mol Med 2021;48:208. [PMID: 34608501 DOI: 10.3892/ijmm.2021.5041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]